Picogram Determination of Finasteride in Human Plasma and Semen by High-Performance Liquid Chromatography with Atmospheric-Pressure Chemical-Ionization Tandem Mass Spectrometry
August 1994
in “Journal of Chromatography B: Biomedical Sciences and Applications”
TLDR Method detects finasteride in plasma and semen with high sensitivity and accuracy.
This document describes a method for detecting the drug finasteride in human plasma and semen using high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry. The method was validated in both plasma and semen, with a high sensitivity of detection allowing for an assay with a limit of quantification of 200 pg per ml of biological fluid. The within-day precision of the assay was less than 10% at all concentrations within the standard curve range, and the assay accuracy at all concentrations both in plasma and semen varied between 94-110%. The recovery of finasteride was ≥ 90% at all concentrations within the standard curve range and was practically the same from plasma and semen.
View this study on sciencedirect.com →
Cited in this study
research High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
Reliable method detects finasteride in human plasma at low doses.
research The clinical development of a 5α-reductase inhibitor, finasteride
Finasteride effectively treats BPH, but needs more trials to understand potential.
research Species Differences in Prostatic Steroid 5α-Reductases of Rat, Dog, and Human
Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.